Ihuman Return On Equity vs. Profit Margin
| IH Stock | USD 1.79 0.08 4.28% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter 0.18887685 | Current Value 0.18 | Quarterly Volatility 4.87314107 |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.52 | 0.7084 |
|
|
For Ihuman profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ihuman to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ihuman Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ihuman's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ihuman Inc over time as well as its relative position and ranking within its peers.
Ihuman |
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.60) | Earnings Share 0.06 | Revenue Per Share 18.727 | Quarterly Revenue Growth (0.11) | Return On Assets 0.0561 |
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Ihuman Inc Profit Margin vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Ihuman's current stock value. Our valuation model uses many indicators to compare Ihuman value to that of its competitors to determine the firm's financial worth. Ihuman Inc is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in profit margin category among its peers fabricating about 0.86 of Profit Margin per Return On Equity. The ratio of Return On Equity to Profit Margin for Ihuman Inc is roughly 1.16 . As of now, Ihuman's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ihuman's earnings, one of the primary drivers of an investment's value.Ihuman Profit Margin vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Ihuman |
| = | 0.18 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Ihuman |
| = | 0.15 % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Ihuman Profit Margin Comparison
Ihuman is currently under evaluation in profit margin category among its peers.
Ihuman Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Ihuman, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Ihuman will eventually generate negative long term returns. The profitability progress is the general direction of Ihuman's change in net profit over the period of time. It can combine multiple indicators of Ihuman, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 26.1 M | 27.4 M | |
| Operating Income | 159.9 M | 167.9 M | |
| Net Income From Continuing Ops | 183.1 M | 192.2 M | |
| Income Before Tax | 202.6 M | 212.7 M | |
| Total Other Income Expense Net | 14.1 M | 12.9 M | |
| Net Income Applicable To Common Shares | 126.3 M | 132.6 M | |
| Net Income | 180.9 M | 190 M | |
| Income Tax Expense | 21.7 M | 22.7 M | |
| Net Interest Income | 28.5 M | 18.4 M | |
| Interest Income | 28.5 M | 18.4 M | |
| Change To Netincome | 37.7 M | 71 M | |
| Net Income Per Share | 3.30 | 3.47 | |
| Income Quality | 0.95 | 1.00 | |
| Net Income Per E B T | 0.89 | 1.07 |
Ihuman Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Ihuman. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Ihuman position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Ihuman's important profitability drivers and their relationship over time.
Use Ihuman in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ihuman position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ihuman will appreciate offsetting losses from the drop in the long position's value.Ihuman Pair Trading
Ihuman Inc Pair Trading Analysis
The ability to find closely correlated positions to Ihuman could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ihuman when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ihuman - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ihuman Inc to buy it.
The correlation of Ihuman is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ihuman moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ihuman Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ihuman can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Ihuman position
In addition to having Ihuman in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Tech Funds Thematic Idea Now
Tech Funds
Funds or Etfs that invest in companies involved in research, development, testing, or distribution of technologically based goods and services. The Tech Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Information and Resources on Investing in Ihuman Stock
When determining whether Ihuman Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ihuman's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ihuman Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ihuman Inc Stock:Check out Risk vs Return Analysis. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
To fully project Ihuman's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Ihuman Inc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Ihuman's income statement, its balance sheet, and the statement of cash flows.